MBD3 (methyl-CpG binding domain protein 3)

2003-06-01  

Identity

HGNC
LOCATION
19p13.3
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 53615
MIM: 603573
HGNC: 6918
Ensembl: ENSG00000071655

Variants:

dbSNP: 53615
ClinVar: 53615
TCGA: ENSG00000071655
COSMIC: MBD3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000071655ENST00000434436O95983
ENSG00000071655ENST00000585903A0A087WVG6
ENSG00000071655ENST00000585967A0A087X1H1
ENSG00000071655ENST00000590550K7EIE8
ENSG00000071655ENST00000592012A0A0A0MTS6
ENSG00000071655ENST00000592361A0A087WT34
ENSG00000071655ENST00000592965A0A087WZ12

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45

Pathways

PathwaySourceExternal ID
Gene ExpressionREACTOMER-HSA-74160
Generic Transcription PathwayREACTOMER-HSA-212436
Transcriptional Regulation by TP53REACTOMER-HSA-3700989
RNA Polymerase I, RNA Polymerase III, and Mitochondrial TranscriptionREACTOMER-HSA-504046
RNA Polymerase I TranscriptionREACTOMER-HSA-73864
RNA Polymerase I Promoter ClearanceREACTOMER-HSA-73854
RNA Polymerase I Transcription InitiationREACTOMER-HSA-73762
Epigenetic regulation of gene expressionREACTOMER-HSA-212165
Chromatin organizationREACTOMER-HSA-4839726
Chromatin modifying enzymesREACTOMER-HSA-3247509
HDACs deacetylate histonesREACTOMER-HSA-3214815
Positive epigenetic regulation of rRNA expressionREACTOMER-HSA-5250913
Regulation of TP53 ActivityREACTOMER-HSA-5633007
Regulation of TP53 Activity through AcetylationREACTOMER-HSA-6804758
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expressionREACTOMER-HSA-427389

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
355013902022MBD3 promotes hepatocellular carcinoma progression and metastasis through negative regulation of tumour suppressor TFPI2.7
360379722022Densely methylated DNA traps Methyl-CpG-binding domain protein 2 but permits free diffusion by Methyl-CpG-binding domain protein 3.5
355013902022MBD3 promotes hepatocellular carcinoma progression and metastasis through negative regulation of tumour suppressor TFPI2.7
360379722022Densely methylated DNA traps Methyl-CpG-binding domain protein 2 but permits free diffusion by Methyl-CpG-binding domain protein 3.5
316666832020Histone deacetylases, Mbd3/NuRD, and Tet2 hydroxylase are crucial regulators of epithelial-mesenchymal plasticity and tumor metastasis.15
321818052020Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation.26
329631822020Methyl-CpG binding domain protein 3: a new diagnostic marker and potential therapeutic target of melanoma.1
316666832020Histone deacetylases, Mbd3/NuRD, and Tet2 hydroxylase are crucial regulators of epithelial-mesenchymal plasticity and tumor metastasis.15
321818052020Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation.26
329631822020Methyl-CpG binding domain protein 3: a new diagnostic marker and potential therapeutic target of melanoma.1
309805932019Structural analyses reveal that MBD3 is a methylated CG binder.7
309805932019Structural analyses reveal that MBD3 is a methylated CG binder.7
303044692018The C-terminal D/E-rich domain of MBD3 is a putative Z-DNA mimic that competes for Zα DNA-binding activity.6
303044692018The C-terminal D/E-rich domain of MBD3 is a putative Z-DNA mimic that competes for Zα DNA-binding activity.6
278940812017MBD3 inhibits formation of liver cancer stem cells.9

Citation

Dessen P

MBD3 (methyl-CpG binding domain protein 3)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/41310/cancer-prone-explorer/js/lib/favicon/apple-touch-icon.png